Browsing "1. Journal Papers" by Author : 2206

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 14 to 24 of 24

This table browses all dspace content
Issue DateTitleJournal Title
2020Intermediate HER2 Expression Is Associated With Poor Prognosis in Estrogen Receptor-Positive Breast Cancer Patients Aged 55 Years and OlderBREAST CANCER RESEARCH AND TREATMENT
2018Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC TrialANNALS OF SURGICAL ONCOLOGY
2023On-treatment derived neutrophil-to-lymphocyte ratio and survival with palbociclib and endocrine treatment: analysis of a multicenter retrospective cohort and the PALOMA-2/3 study with immune correlates BREAST CANCER RESEARCH
2020Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancerBREAST CANCER RESEARCH AND TREATMENT
2022Phase II Clinical Trial of Eribulin-Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or LeiomyosarcomaCLINICAL CANCER RESEARCH
2017Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon CancerANNALS OF SURGICAL ONCOLOGY
2021Real-World Clinical Outcomes of Biosimilar Trastuzumab (CT-P6) in HER2-Positive Early-Stage and Metastatic Breast Cancer FRONTIERS IN ONCOLOGY
2023Resolution of Nonmass Enhancement Extension to the Nipple at Breast MRI after Neoadjuvant Chemotherapy: Pathologic Response and Feasibility for Nipple-sparing MastectomyRADIOLOGY
2017Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery BMC CANCER
2022SP142 PD-L1 Assays in Multiple Samples from the Same Patients with Early or Advanced Triple-Negative Breast Cancer CANCERS
2023YAP1 Expression in HR+HER2- Breast Cancer: 21-Gene Recurrence Score Analysis and Public Dataset Validation CANCERS
1

Browse

Links